Literature DB >> 24027428

RNF115/BCA2 E3 ubiquitin ligase promotes breast cancer cell proliferation through targeting p21Waf1/Cip1 for ubiquitin-mediated degradation.

Zehua Wang1, Zhi Nie, Wenlin Chen, Zhongmei Zhou, Qinghua Kong, Arun K Seth, Rong Liu, Ceshi Chen.   

Abstract

The E3 ubiquitin ligase RING finger protein 115 (RNF115), also known as breast cancer-associated gene 2 (BCA2), has previously been reported to be overexpressed in estrogen receptor α (ERα)-positive breast tumors and to promote breast cell proliferation; however, its mechanism is unknown. In this study, we demonstrated that silencing of BCA2 by small interfering RNAs (siRNAs) in two ERα-positive breast cancer cell lines, MCF-7 and T47D, decreases cell proliferation and increases the protein levels of the cyclin-dependent kinase inhibitor p21Waf/Cip1. The protein stability of p21 was negatively regulated by BCA2. BCA2 directly interacts with p21 and promotes p21 ubiquitination and proteasomal degradation. Knockdown of p21 partially rescues the cell growth arrest induced by the BCA2 siRNA. These results suggest that BCA2 promotes ERα-positive breast cancer cell proliferation at least partially through downregulating the expression of p21.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24027428      PMCID: PMC3769882          DOI: 10.1593/neo.13678

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  24 in total

1.  Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.

Authors:  D M Koepp; L K Schaefer; X Ye; K Keyomarsi; C Chu; J W Harper; S J Elledge
Journal:  Science       Date:  2001-08-30       Impact factor: 47.728

2.  Cip/Kip proteins: more than just CDKs inhibitors.

Authors:  Catherine Denicourt; Steven F Dowdy
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

3.  Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7.

Authors:  Masayoshi Yada; Shigetsugu Hatakeyama; Takumi Kamura; Masaaki Nishiyama; Ryosuke Tsunematsu; Hiroyuki Imaki; Noriko Ishida; Fumihiko Okumura; Keiko Nakayama; Keiichi I Nakayama
Journal:  EMBO J       Date:  2004-04-22       Impact factor: 11.598

4.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.

Authors:  A C Carrano; E Eytan; A Hershko; M Pagano
Journal:  Nat Cell Biol       Date:  1999-08       Impact factor: 28.824

Review 5.  KLF4, p21 and context-dependent opposing forces in cancer.

Authors:  Benjamin D Rowland; Daniel S Peeper
Journal:  Nat Rev Cancer       Date:  2006-01       Impact factor: 60.716

6.  E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation.

Authors:  Xu Zhi; Dong Zhao; Zehua Wang; Zhongmei Zhou; Chunyan Wang; Wenlin Chen; Rong Liu; Ceshi Chen
Journal:  Cancer Res       Date:  2012-10-01       Impact factor: 12.701

7.  A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer.

Authors:  Angelika M Burger; Yuguang Gao; Yutaka Amemiya; Harriette J Kahn; Richard Kitching; Yili Yang; Ping Sun; Steven A Narod; Wedad M Hanna; Arun K Seth
Journal:  Cancer Res       Date:  2005-11-15       Impact factor: 12.701

8.  Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins.

Authors:  Z K Yu; J L Gervais; H Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 9.  Lost in transcription: p21 repression, mechanisms, and consequences.

Authors:  Andrei L Gartel; Senthil K Radhakrishnan
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

10.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation.

Authors:  Markus Welcker; Amir Orian; Jianping Jin; Jonathan E Grim; Jonathan A Grim; J Wade Harper; Robert N Eisenman; Bruce E Clurman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-18       Impact factor: 11.205

View more
  15 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

Review 2.  The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.

Authors:  Richard Arkwright; Tri Minh Pham; Jeffrey A Zonder; Q Ping Dou
Journal:  Expert Opin Drug Discov       Date:  2016-12-20       Impact factor: 6.098

Review 3.  Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases.

Authors:  Mei-Xia Wang; Tianzi Liuyu; Zhi-Dong Zhang
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

4.  Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer.

Authors:  Kyriaki Michailidou; Jonathan Beesley; Sara Lindstrom; Sander Canisius; Joe Dennis; Michael J Lush; Mel J Maranian; Manjeet K Bolla; Qin Wang; Mitul Shah; Barbara J Perkins; Kamila Czene; Mikael Eriksson; Hatef Darabi; Judith S Brand; Stig E Bojesen; Børge G Nordestgaard; Henrik Flyger; Sune F Nielsen; Nazneen Rahman; Clare Turnbull; Olivia Fletcher; Julian Peto; Lorna Gibson; Isabel dos-Santos-Silva; Jenny Chang-Claude; Dieter Flesch-Janys; Anja Rudolph; Ursula Eilber; Sabine Behrens; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Sofia Khan; Kirsimari Aaltonen; Habibul Ahsan; Muhammad G Kibriya; Alice S Whittemore; Esther M John; Kathleen E Malone; Marilie D Gammon; Regina M Santella; Giske Ursin; Enes Makalic; Daniel F Schmidt; Graham Casey; David J Hunter; Susan M Gapstur; Mia M Gaudet; W Ryan Diver; Christopher A Haiman; Fredrick Schumacher; Brian E Henderson; Loic Le Marchand; Christine D Berg; Stephen J Chanock; Jonine Figueroa; Robert N Hoover; Diether Lambrechts; Patrick Neven; Hans Wildiers; Erik van Limbergen; Marjanka K Schmidt; Annegien Broeks; Senno Verhoef; Sten Cornelissen; Fergus J Couch; Janet E Olson; Emily Hallberg; Celine Vachon; Quinten Waisfisz; Hanne Meijers-Heijboer; Muriel A Adank; Rob B van der Luijt; Jingmei Li; Jianjun Liu; Keith Humphreys; Daehee Kang; Ji-Yeob Choi; Sue K Park; Keun-Young Yoo; Keitaro Matsuo; Hidemi Ito; Hiroji Iwata; Kazuo Tajima; Pascal Guénel; Thérèse Truong; Claire Mulot; Marie Sanchez; Barbara Burwinkel; Frederik Marme; Harald Surowy; Christof Sohn; Anna H Wu; Chiu-chen Tseng; David Van Den Berg; Daniel O Stram; Anna González-Neira; Javier Benitez; M Pilar Zamora; Jose Ignacio Arias Perez; Xiao-Ou Shu; Wei Lu; Yu-Tang Gao; Hui Cai; Angela Cox; Simon S Cross; Malcolm W R Reed; Irene L Andrulis; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Annika Lindblom; Sara Margolin; Soo Hwang Teo; Cheng Har Yip; Nur Aishah Mohd Taib; Gie-Hooi Tan; Maartje J Hooning; Antoinette Hollestelle; John W M Martens; J Margriet Collée; William Blot; Lisa B Signorello; Qiuyin Cai; John L Hopper; Melissa C Southey; Helen Tsimiklis; Carmel Apicella; Chen-Yang Shen; Chia-Ni Hsiung; Pei-Ei Wu; Ming-Feng Hou; Vessela N Kristensen; Silje Nord; Grethe I Grenaker Alnaes; Graham G Giles; Roger L Milne; Catriona McLean; Federico Canzian; Dimitrios Trichopoulos; Petra Peeters; Eiliv Lund; Malin Sund; Kay-Tee Khaw; Marc J Gunter; Domenico Palli; Lotte Maxild Mortensen; Laure Dossus; Jose-Maria Huerta; Alfons Meindl; Rita K Schmutzler; Christian Sutter; Rongxi Yang; Kenneth Muir; Artitaya Lophatananon; Sarah Stewart-Brown; Pornthep Siriwanarangsan; Mikael Hartman; Hui Miao; Kee Seng Chia; Ching Wan Chan; Peter A Fasching; Alexander Hein; Matthias W Beckmann; Lothar Haeberle; Hermann Brenner; Aida Karina Dieffenbach; Volker Arndt; Christa Stegmaier; Alan Ashworth; Nick Orr; Minouk J Schoemaker; Anthony J Swerdlow; Louise Brinton; Montserrat Garcia-Closas; Wei Zheng; Sandra L Halverson; Martha Shrubsole; Jirong Long; Mark S Goldberg; France Labrèche; Martine Dumont; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Hiltrud Brauch; Ute Hamann; Thomas Brüning; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Loris Bernard; Natalia V Bogdanova; Thilo Dörk; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Peter Devilee; Robert A E M Tollenaar; Caroline Seynaeve; Christi J Van Asperen; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Tomasz Huzarski; Suleeporn Sangrajrang; Valerie Gaborieau; Paul Brennan; James McKay; Susan Slager; Amanda E Toland; Christine B Ambrosone; Drakoulis Yannoukakos; Maria Kabisch; Diana Torres; Susan L Neuhausen; Hoda Anton-Culver; Craig Luccarini; Caroline Baynes; Shahana Ahmed; Catherine S Healey; Daniel C Tessier; Daniel Vincent; Francois Bacot; Guillermo Pita; M Rosario Alonso; Nuria Álvarez; Daniel Herrero; Jacques Simard; Paul P D P Pharoah; Peter Kraft; Alison M Dunning; Georgia Chenevix-Trench; Per Hall; Douglas F Easton
Journal:  Nat Genet       Date:  2015-03-09       Impact factor: 38.330

5.  The Role of BCA2 in the Endocytic Trafficking of EGFR and Significance as a Prognostic Biomarker in Cancer.

Authors:  Jennifer M Wymant; Stephen Hiscox; Andrew D Westwell; Sylvie Urbé; Michael J Clague; Arwyn T Jones
Journal:  J Cancer       Date:  2016-12-09       Impact factor: 4.207

6.  Regulation of DNA Damage Response by Estrogen Receptor β-Mediated Inhibition of Breast Cancer Associated Gene 2.

Authors:  Yuan-Hao Lee; Youping Sun; Leo E Gerweck; Randolph D Glickman
Journal:  Biomedicines       Date:  2015-04-21

7.  Allele-specific miRNA-binding analysis identifies candidate target genes for breast cancer risk.

Authors:  Ana Jacinta-Fernandes; Joana M Xavier; Ramiro Magno; Joel G Lage; Ana-Teresa Maia
Journal:  NPJ Genom Med       Date:  2020-02-13       Impact factor: 8.617

8.  Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response.

Authors:  Norbert Nass; Angela Dittmer; Vicky Hellwig; Theresia Lange; Johanna Mirjam Beyer; Benjamin Leyh; Atanas Ignatov; Christine Weiβenborn; Tove Kirkegaard; Anne E Lykkesfeldt; Thomas Kalinski; Jürgen Dittmer
Journal:  Oncotarget       Date:  2016-06-21

9.  Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.

Authors:  Qin Lu; Dayun Lu; Zhi-Ming Shao; Da-Qiang Li
Journal:  Cancer Sci       Date:  2019-02-21       Impact factor: 6.716

10.  RNF115 deletion inhibits autophagosome maturation and growth of gastric cancer.

Authors:  Riyong Li; Zhaohui Gu; Xuan Zhang; Jiahong Yu; Jinqiu Feng; Yaxin Lou; Ping Lv; Yingyu Chen
Journal:  Cell Death Dis       Date:  2020-09-26       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.